USANA Health Sciences, Inc.
USNA
$19.41
-$0.50-2.51%
NYSE
| 04/04/2026 | 01/03/2026 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.52M | -1.78M | -6.52M | 9.66M | 9.40M |
| Total Depreciation and Amortization | 9.79M | 10.29M | 9.57M | 9.60M | 10.25M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.32M | 6.27M | 5.92M | -2.57M | 5.33M |
| Change in Net Operating Assets | -13.86M | -18.17M | -10.93M | -4.48M | -9.50M |
| Cash from Operations | 9.76M | -3.39M | -1.96M | 12.22M | 15.48M |
| Capital Expenditure | -2.65M | -2.80M | -3.20M | -5.03M | -2.80M |
| Sale of Property, Plant, and Equipment | 48.00K | 3.91M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 865.00K | -1.07M |
| Cash from Investing | -2.60M | 1.11M | -3.20M | -4.16M | -3.88M |
| Total Debt Issued | 4.00M | 16.00M | 0.00 | 1.60M | -- |
| Total Debt Repaid | -4.00M | -2.00M | 0.00 | -24.60M | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.27M | -56.00K | -100.00K | -15.23M | -14.47M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.38M | -491.00K | -879.00K | -379.00K | -- |
| Cash from Financing | -3.64M | 13.45M | -979.00K | -38.61M | -14.47M |
| Foreign Exchange rate Adjustments | 896.00K | 1.91M | 165.00K | 2.31M | 719.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.42M | 13.09M | -5.97M | -28.24M | -2.14M |